Fuji Pharma Co., Ltd.

64
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3816200004
JPY
2,276.00
50 (2.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
No of Months
12
12
12
12
12
12
Operating Income
51,677.00
46,138.00
40,889.00
35,426.00
33,990.00
33,793.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
51,677.00
46,138.00
40,889.00
35,426.00
33,990.00
33,793.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
330.00
196.00
121.00
77.00
53.00
37.00
General and Administration Expenses
10,957.00
9,231.00
8,331.00
7,355.00
8,340.00
8,048.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
46,687.00
42,257.00
37,030.00
31,648.00
30,641.00
30,653.00
Operating Profit (PBDIT) excl Other Income
4,990.00
3,881.00
3,859.00
3,778.00
3,349.00
3,140.00
Other Income
79.00
3,246.00
417.00
309.00
86.00
-184.00
Operating Profit (PBDIT)
9,034.00
10,807.00
7,299.00
6,832.00
5,541.00
5,013.00
Interest
330.00
196.00
121.00
77.00
53.00
37.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
3,965.00
3,680.00
3,023.00
2,745.00
2,106.00
2,057.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
4,000.00
8,276.00
4,399.00
3,723.00
3,371.00
2,918.00
Provision for Tax
1,000.00
2,128.00
963.00
1,026.00
938.00
832.00
Profit After Tax
3,000.00
6,147.00
3,435.00
2,697.00
2,432.00
2,085.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
122.93
252.81
141.35
110.98
90.52
66.92
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Sep 2025 is 12.01% vs 12.84% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Sep 2025 is 28.58% vs 0.57% in Sep 2024

stock-summary

Interest

YoY Growth in year ended Sep 2025 is 68.37% vs 61.98% in Sep 2024

stock-summary

Profit After Tax

YoY Growth in year ended Sep 2025 is -51.20% vs 78.95% in Sep 2024

Compare Profit and Loss Results of Fuji Pharma Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
51,677.00
50,643.00
1,034.00
2.04%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
51,677.00
50,643.00
1,034.00
2.04%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
330.00
123.00
207.00
168.29%
General and Administration Expenses
10,957.00
3,333.00
7,624.00
228.74%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
46,687.00
48,022.00
-1,335.00
-2.78%
Operating Profit (PBDIT) excl Other Income
4,990.00
2,621.00
2,369.00
90.39%
Other Income
79.00
493.00
-414.00
-83.98%
Operating Profit (PBDIT)
9,034.00
7,446.00
1,588.00
21.33%
Interest
330.00
123.00
207.00
168.29%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
3,965.00
4,332.00
-367.00
-8.47%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
4,000.00
2,958.00
1,042.00
35.23%
Provision for Tax
1,000.00
1,192.00
-192.00
-16.11%
Profit After Tax
3,000.00
1,908.00
1,092.00
57.23%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
122.9346
62.7198
60.21
96.01%
Profit And Loss - Net Sales
Net Sales 51,677.00 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is 12.01% vs 12.84% in Sep 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4,990.00 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is 28.58% vs 0.57% in Sep 2024

Profit And Loss - Interest
Interest 330.00 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is 68.37% vs 61.98% in Sep 2024

Profit And Loss - Profit After Tax
Profit After Tax 3,000.00 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is -51.20% vs 78.95% in Sep 2024